Skip to main content

Advertisement

Table 1 Sensitivity for the detection of intraperitoneal lesions with PET and BLI depending on the site of the tumour

From: Non-invasive imaging of implanted peritoneal carcinomatosis in mice using PET and bioluminescence imaging

n Site or region Volume range Sensitivity PET Sensitivity BLI
   [mm3] [%] [%]
8 Injection site 0.3–9.0 63 (5/8) 100 (8/8)
2 Peritoneum 1.0–1.8 50 (1/2) 100 (2/2)
7 Diaphragm 0.1–1.8 14 (1/7) 0 (0/7)
13 Liver surface 0.5–3.0 85 (11/13) 8 (1/13)
1 Stomach 0.5 100 (1/1) 0 (0/1)
1 Duodenum 3.0 100 (1/1) 0 (0/1)
21 Jejunum 0.5–10.0 84 (16/21) 48 (10/21)
6 Colon 0.5–6.0 80 (4/6) 33 (2/6)
19 Pancreas 1.0–18 83 (15/19) 79 (15/19)
2 Uterus 1.8–3.0 100 (2/2) 100 (2/2)
2 Bladder 1.8–4.0 50 (1/2) 0 (0/2)
82 Total 0.1–18.0 74 (58/82)* 49 (40/82)*
  1. The table shows the number of malignant lesions [n] with respect to different sites, the volume range and the sensitivities for PET and BLI. The difference between PET and BLI was significant at p < 0.05 (*chi-square 8.2152; p value 0.004154)